Los Angeles Capital Management LLC lifted its position in Enhabit, Inc. (NYSE:EHAB – Free Report) by 106.4% in the third quarter, according to its most recent Form 13F filing with the SEC. The firm owned 50,883 shares of the company’s stock after purchasing an additional 26,227 shares during the period. Los Angeles Capital Management LLC’s holdings in Enhabit were worth $402,000 at the end of the most recent quarter.
A number of other large investors have also recently modified their holdings of the company. Stoneridge Investment Partners LLC purchased a new stake in Enhabit during the third quarter worth $81,000. Point72 Asia Singapore Pte. Ltd. purchased a new stake in Enhabit during the second quarter worth $106,000. Quarry LP lifted its holdings in Enhabit by 242.2% during the second quarter. Quarry LP now owns 3,703 shares of the company’s stock worth $33,000 after buying an additional 2,621 shares during the period. Algert Global LLC purchased a new stake in Enhabit during the second quarter worth $136,000. Finally, AQR Capital Management LLC purchased a new stake in Enhabit during the second quarter worth $94,000.
Enhabit Stock Down 1.2 %
Enhabit stock opened at $7.35 on Monday. The business has a fifty day moving average of $7.56 and a two-hundred day moving average of $8.47. The company has a quick ratio of 1.48, a current ratio of 1.46 and a debt-to-equity ratio of 0.85. The firm has a market cap of $369.56 million, a P/E ratio of -3.17 and a beta of 1.84. Enhabit, Inc. has a twelve month low of $6.85 and a twelve month high of $11.74.
Insider Transactions at Enhabit
In other news, Director Jeffrey Bolton bought 5,000 shares of the business’s stock in a transaction that occurred on Thursday, August 22nd. The shares were purchased at an average cost of $8.01 per share, with a total value of $40,050.00. Following the transaction, the director now directly owns 78,877 shares in the company, valued at approximately $631,804.77. The trade was a 6.77 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 1.90% of the company’s stock.
Enhabit Company Profile
Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.
Further Reading
- Five stocks we like better than Enhabit
- Learn Technical Analysis Skills to Master the Stock Market
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Are Penny Stocks a Good Fit for Your Portfolio?
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Why Are These Companies Considered Blue Chips?
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Want to see what other hedge funds are holding EHAB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Enhabit, Inc. (NYSE:EHAB – Free Report).
Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.